• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构和配体的虚拟筛选发现疫苗佐剂:新型类 Toll 样受体 4(TLR4)色胺相关激动剂的合理设计。

Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery.

机构信息

Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic.

Department of Forensic Medicine and Intensive Medicine, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava 70300, Czech Republic.

出版信息

Molecules. 2018 Jan 4;23(1):102. doi: 10.3390/molecules23010102.

DOI:10.3390/molecules23010102
PMID:29300367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6017214/
Abstract

In order to identify novel lead structures for human toll-like receptor 4 (TLR4) modulation virtual high throughput screening by a peta-flops-scale supercomputer has been performed. Based on the in silico studies, a series of 12 compounds related to tryptamine was rationally designed to retain suitable molecular geometry for interaction with the TLR4 binding site as well as to satisfy general principles of drug-likeness. The proposed compounds were synthesized, and tested by in vitro and ex vivo experiments, which revealed that several of them are capable to stimulate TLR4 in vitro up to 25% activity of Monophosphoryl lipid A. The specific affinity of the in vitro most potent substance was confirmed by surface plasmon resonance direct-binding experiments. Moreover, two compounds from the series show also significant ability to elicit production of interleukin 6.

摘要

为了鉴定人 toll 样受体 4(TLR4)调节的新型先导结构,我们使用了 petaflops 级别的超级计算机进行了虚拟高通量筛选。基于计算机模拟研究,我们合理设计了一系列 12 种与色胺有关的化合物,以保持与 TLR4 结合位点相互作用的合适分子几何形状,并满足药物相似性的一般原则。所提出的化合物被合成,并通过体外和体内实验进行了测试,结果表明其中一些化合物在体外能够刺激 TLR4,其活性高达单磷酰脂质 A 的 25%。通过表面等离子体共振直接结合实验证实了体外最有效物质的特定亲和力。此外,该系列中的两种化合物还显示出诱导白细胞介素 6 产生的显著能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/eb29101df9ee/molecules-23-00102-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/61f89b26f3e0/molecules-23-00102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/9221e006309b/molecules-23-00102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/3e1444960e7c/molecules-23-00102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/036d2213e651/molecules-23-00102-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/a6bd65491666/molecules-23-00102-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/f04ab7595cf1/molecules-23-00102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/fc6bcdf9f34f/molecules-23-00102-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/6ac5489f9517/molecules-23-00102-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/eb29101df9ee/molecules-23-00102-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/61f89b26f3e0/molecules-23-00102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/9221e006309b/molecules-23-00102-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/3e1444960e7c/molecules-23-00102-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/036d2213e651/molecules-23-00102-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/a6bd65491666/molecules-23-00102-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/f04ab7595cf1/molecules-23-00102-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/fc6bcdf9f34f/molecules-23-00102-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/6ac5489f9517/molecules-23-00102-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2354/6017214/eb29101df9ee/molecules-23-00102-g007.jpg

相似文献

1
Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery.基于结构和配体的虚拟筛选发现疫苗佐剂:新型类 Toll 样受体 4(TLR4)色胺相关激动剂的合理设计。
Molecules. 2018 Jan 4;23(1):102. doi: 10.3390/molecules23010102.
2
Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro.通过计算机筛选合理设计新型 TLR4 配体,并在体外对其功能和结构进行表征。
Eur J Med Chem. 2018 Feb 25;146:38-46. doi: 10.1016/j.ejmech.2017.12.074. Epub 2018 Jan 11.
3
Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening.基于结构和配体的虚拟筛选鉴定新型 Toll 样受体 4(TLR4)拮抗剂。
Eur J Med Chem. 2013;70:393-9. doi: 10.1016/j.ejmech.2013.10.019. Epub 2013 Oct 12.
4
Enhanced immunostimulatory activity of in silico discovered agonists of Toll-like receptor 2 (TLR2).经计算机预测发现的 Toll 样受体 2(TLR2)激动剂的免疫刺激活性增强。
Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2680-2689. doi: 10.1016/j.bbagen.2017.07.011. Epub 2017 Jul 19.
5
TLR4 agonists as immunomodulatory agents.作为免疫调节剂的Toll样受体4激动剂
J Endotoxin Res. 2006;12(5):313-9. doi: 10.1179/096805106X118753.
6
An in silico approach towards the identification of novel inhibitors of the TLR-4 signaling pathway.一种用于鉴定Toll样受体4(TLR-4)信号通路新型抑制剂的计算机模拟方法。
J Biomol Struct Dyn. 2016 Jun;34(6):1345-62. doi: 10.1080/07391102.2015.1079243. Epub 2015 Sep 2.
7
Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity.鉴定具有生物活性的嘧啶并[5,4-b]吲哚,其可延长NF-κB激活但无内在活性。
ACS Comb Sci. 2017 Aug 14;19(8):533-543. doi: 10.1021/acscombsci.7b00080. Epub 2017 Jul 13.
8
A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.一类对人TLR4激活的偏好性高于小鼠TLR4激活的新型小分子激动剂。
PLoS One. 2016 Oct 13;11(10):e0164632. doi: 10.1371/journal.pone.0164632. eCollection 2016.
9
The science of vaccine adjuvants: advances in TLR4 ligand adjuvants.疫苗佐剂的科学:TLR4 配体佐剂的进展。
Curr Opin Immunol. 2016 Aug;41:85-90. doi: 10.1016/j.coi.2016.06.007. Epub 2016 Jul 5.
10
Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.评估Toll样受体4和7/8激动剂在BALB/c小鼠利什曼病疫苗中的佐剂作用。
Mol Immunol. 2017 Nov;91:202-208. doi: 10.1016/j.molimm.2017.09.010. Epub 2017 Sep 30.

引用本文的文献

1
Investigate the binding of pesticides with the TLR4 receptor protein found in mammals and zebrafish using molecular docking and molecular dynamics simulations.采用分子对接和分子动力学模拟研究哺乳动物和斑马鱼中 TLR4 受体蛋白与农药的结合。
Sci Rep. 2024 Oct 18;14(1):24504. doi: 10.1038/s41598-024-75527-6.
2
Renal Ischemia/Reperfusion Mitigation via Geraniol: The Role of Nrf-2/HO-1/NQO-1 and TLR2,4/MYD88/NFκB Pathway.香叶醇减轻肾缺血/再灌注损伤:Nrf-2/HO-1/NQO-1和TLR2,4/MYD88/NFκB信号通路的作用
Antioxidants (Basel). 2022 Aug 13;11(8):1568. doi: 10.3390/antiox11081568.
3
Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants.

本文引用的文献

1
Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States.美国麻疹疫苗犹豫的公共卫生与经济后果
JAMA Pediatr. 2017 Sep 1;171(9):887-892. doi: 10.1001/jamapediatrics.2017.1695.
2
Vaccine Ingredients: Components that Influence Vaccine Efficacy.疫苗成分:影响疫苗效力的组成部分。
Mini Rev Med Chem. 2017;17(5):451-466. doi: 10.2174/1389557516666160801103303.
3
Potentiation of Resistance to Conventional Antibiotics through Small Molecule Adjuvants.通过小分子佐剂增强对传统抗生素的耐药性
机器学习辅助筛选草药提取物作为疫苗佐剂。
Front Immunol. 2022 May 19;13:847616. doi: 10.3389/fimmu.2022.847616. eCollection 2022.
4
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview.增加基于小分子的 TLR4 调节剂的化学多样性:概述。
Front Immunol. 2020 Jul 10;11:1210. doi: 10.3389/fimmu.2020.01210. eCollection 2020.
5
TLR4-Targeting Therapeutics: Structural Basis and Computer-Aided Drug Discovery Approaches.TLR4 靶向治疗药物:结构基础与计算机辅助药物发现方法。
Molecules. 2020 Jan 31;25(3):627. doi: 10.3390/molecules25030627.
6
Computational tools for modern vaccine development.用于现代疫苗开发的计算工具。
Hum Vaccin Immunother. 2020 Mar 3;16(3):723-735. doi: 10.1080/21645515.2019.1670035. Epub 2019 Dec 18.
Medchemcomm. 2016 Jan 1;7(1):128-131. doi: 10.1039/C5MD00353A. Epub 2015 Sep 30.
4
Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists.潜在合成疫苗佐剂-TLR激动剂的结构特性
Curr Med Chem. 2015;22(29):3306-25. doi: 10.2174/0929867322666150821094634.
5
Optimization of Rutaecarpine as ABCA1 Up-Regulator for Treating Atherosclerosis.吴茱萸次碱作为ABCA1上调剂治疗动脉粥样硬化的优化研究
ACS Med Chem Lett. 2014 Jun 24;5(8):884-8. doi: 10.1021/ml500131a. eCollection 2014 Aug 14.
6
g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations.g_mmpbsa——一种用于高通量MM-PBSA计算的GROMACS工具。
J Chem Inf Model. 2014 Jul 28;54(7):1951-62. doi: 10.1021/ci500020m. Epub 2014 Jun 19.
7
Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening.基于结构和配体的虚拟筛选鉴定新型 Toll 样受体 4(TLR4)拮抗剂。
Eur J Med Chem. 2013;70:393-9. doi: 10.1016/j.ejmech.2013.10.019. Epub 2013 Oct 12.
8
Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligands.鉴定取代的嘧啶并[5,4-b]吲哚为选择性 Toll 样受体 4 配体。
J Med Chem. 2013 Jun 13;56(11):4206-23. doi: 10.1021/jm301694x. Epub 2013 May 24.
9
Targeting Toll-like receptors with small molecule agents.靶向 Toll 样受体的小分子药物。
Chem Soc Rev. 2013 Jun 21;42(12):4859-66. doi: 10.1039/c3cs60039d.
10
Blocking toll-like receptor 2 and 4 signaling during a stressor prevents stress-induced priming of neuroinflammatory responses to a subsequent immune challenge.阻断应激期间的 toll 样受体 2 和 4 信号传导可防止应激引起的神经炎症反应对随后的免疫挑战产生启动作用。
Brain Behav Immun. 2013 Aug;32:112-21. doi: 10.1016/j.bbi.2013.03.004. Epub 2013 Mar 15.